關於 cookie 的說明

本網站使用瀏覽器紀錄 (Cookies) 來提供您最好的使用體驗,我們使用的 Cookie 也包括了第三方 Cookie。相關資訊請訪問我們的隱私權與 Cookie 政策。如果您選擇繼續瀏覽或關閉這個提示,便表示您已接受我們的網站使用條款。

ACE Biotek and Proscend Sign Memorandum of Understanding - Collaborating to Create a New Era of 5G Smart Healthcare

文章來源 : 筑波醫電股份有限公司 發表時間 : 瀏覽次數 : 2487 加入收藏 :

Hsinchu, Taiwan - ACE Biotek and Proscend officially signed a MOU on June 12, 2023. The signing ceremony was attended by Mr. Steve Hsu, Chairman of ACE Biotek, and Mr. Jim Chen, Chairman of Proscend. The collaboration aims to strengthen cooperation in the fields of 5G private networks, AIoT, AI, and DS gateways for smart internet and smart hospitals, with the goal of creating mutual value.

 

Both companies will collaborate on integrating solutions for the application of 5G and AIoT in smart IoT and smart hospital environments. Proscend brings its expertise in 5G and Edge AI technologies, while ACE Biotek contributes its knowledge in AI, Uniiform, DS gateways, and other hardware and software applications. Through this partnership, the companies will jointly develop comprehensive solutions that meet market demands. ACE Biotek is committed to the development of smart healthcare solutions, encompassing wireless communication testing, AI technology, and medical data transmission. Proscend focuses on the research and design of 5G and AIoT vertical applications and smart internet services. This collaboration presents new opportunities for the advancement of 5G smart healthcare.

 

Mr. Steve Hsu, Chairman of ACE Biotek, expressed his enthusiasm, stating, "Emerging technologies such as 5G and AIoT have immense potential in the field of smart healthcare. We look forward to collaborating with Proscend to develop innovative solutions that facilitate telemedicine and integrate medical data, ultimately providing healthcare professionals with greater convenience and delivering increased value to the healthcare industry." Mr. Jim Chen, Chairman of Proscend, added, "We have established ourselves as pioneers in the digital application of 5G and AIoT in Taiwan and have expanded our reach to encompass diverse business opportunities. This partnership will leverage the strengths of both companies, driving the development of 5G smart healthcare and introducing intelligent and advanced technological applications to the medical industry."

To further promote the achievements of this collaboration, ACE Biotek and Proscend will host the "5G x Smart Healthcare Cross-Border Seminar" on June 29th. The seminar will feature presentations by industry leaders and professionals in the fields of Proscend, ACE Biotek, Transnet, Embestor, and hospital information systems/platforms. Attendees will have the opportunity to gain in-depth insights into the latest trends and applications of 5G, AIoT, and smart healthcare. Advanced registration is now open at the following website:

Online Registration: https://register.acesolution.com.tw/20230629_5GxSmartHealth_Seminar

 

About Proscend

Founded in 1999, Proscend is a leading provider of industrial IoT connectivity solutions, empowering the future of 5G and AIoT innovation. With a commitment to excellence and continuous improvement, Proscend stands at the forefront of creating unique and differentiated solutions, guiding us towards an infinite future. With an agile and customer-centric approach, Proscend serves over 60 countries globally as a trusted partner, delivering high-quality industrial-grade networking equipment and optimized IoT management platforms. By offering top-notch and robust solutions, Proscend enables efficient and intelligent transformations across multiple industries, including smart cities, smart transportation, smart energy, smart retail, and smart healthcare. Proscend is dedicated to fostering a symbiotic, prosperous, and sustainable world.

 

Contact Proscend

Proscend Communications Inc.

Address: 2F, No. 36, Industrial East 4th Rd., Hsinchu Science Park, Hsinchu City 300093, Taiwan

Phone: +886-3-5639000

E-mail: sales@proscend.com

Website: https://www.proscend.com/

 

About ACE Biotek

Established in 2000, ACE Group has grown over 20 years across wireless and healthcare industries. ACE Biotek, founded in 2018 by President Steve Hsu, integrates 20 years of industrial experience and knowledge to solve unmet clinical needs. ACE Biotek develops smart medical solutions encompassing imaging algorithms, cloud computing, artificial intelligence, and terahertz technology, with a focus on achieving early disease diagnosis. In the long term, ACE Biotek aims to expand globally, serving as a platform to foster talent and support tech companies in their transformation into Medtech.

 

Contact ACE Biotek

Advanced ACE Biotek Co., Ltd.

Address: Hsinchu Biomedical Science Park, No. 66, Shengyi 2nd Rd., Zhubei City, Hsinchu County 302, Taiwan

Phone: +886-3-5500909

E-mail: service@acebiotek.com

Website: https://www.acebiotek.com/

Facebook: https://www.facebook.com/Acebiotek/

LinkedIn: https://www.linkedin.com/company/30620922/admin/

以上新聞投稿內容由 筑波醫電股份有限公司 全權自負責任,若有涉及任何違反法令、違反本網站會員條款、有侵害第三人權益之虞,將一概由 筑波醫電股份有限公司 承擔法律及損害賠償之責任,與台灣產經新聞網無關。

Tags :
2025 年 2 月 13 日 (星期四) 農曆正月十六日
首 頁 我的收藏 搜 尋 新聞發佈